Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
54 studies found for:    Open Studies | "Gastritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gastritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Linked Color Imaging/Magnifying Blue Laser Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
Conditions: Gastritis;   Helicobacter Pylori Associated Gastritis;   Atrophic Gastritis
Intervention: Device: Digital chromoendoscopy and magnification
2 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
3 Recruiting Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Conditions: Gastroenteritis;   Gastritis
Intervention: Drug: RHB-102
4 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
5 Recruiting Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Gastroenteritis;   Eosinophilic Colitis
6 Unknown  Esomeprazole Treatment for Patients With Lymphocytic Gastritis
Condition: Lymphocytic Gastritis
Intervention: Drug: Esomeprazole
7 Unknown  A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Conditions: Acute Gastritis;   Chronic Gastritis
Interventions: Drug: DA-6034;   Drug: Rebamipide 300mg
8 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
9 Not yet recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
Conditions: Chronic Atrophic Gastritis;   Intestinal Metaplasia of Gastric Mucosa
Interventions: Drug: Curcumin;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment
10 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
11 Not yet recruiting System Biology of Spleen Deficiency Syndrome
Conditions: Gastritis, Atrophic;   Gastric Cancer
12 Recruiting Gastric Cancer Screening Quality Improvement System Establishment
Conditions: Gastric Cancer;   Gastritis, Atrophic;   Intestinal Metaplasia
Intervention: Behavioral: Education and feedback
13 Unknown  The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure
Condition: Gastritis
Intervention: Procedure: Resting Energy Expenditure examination
14 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
15 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
16 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
17 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
18 Unknown  Gastropanel for Gastric Atrophy and Cancer Risk Assessment
Conditions: Gastritis, Atrophic;   Stomach Neoplasms
Interventions: Procedure: GastroPanel test;   Procedure: Gastroscopy
19 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
20 Not yet recruiting A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
Condition: Gastritis
Interventions: Device: The results of clarithromycin susceptibility test of H. pylori isolates;   Device: Computer generated random number, randomly assigned into groups;   Device: The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years